Sumitomo Mitsui Trust Holdings Inc. purchased a new position in Integer Holdings Corp (NYSE:ITGR) in the third quarter, HoldingsChannel reports. The institutional investor purchased 12,000 shares of the medical equipment provider’s stock, valued at approximately $907,000.
Several other hedge funds and other institutional investors also recently bought and sold shares of the business. WINTON GROUP Ltd raised its position in shares of Integer by 112.7% in the second quarter. WINTON GROUP Ltd now owns 8,158 shares of the medical equipment provider’s stock worth $685,000 after buying an additional 4,322 shares in the last quarter. Zions Bancorporation N.A. raised its position in shares of Integer by 6.2% in the second quarter. Zions Bancorporation N.A. now owns 3,278 shares of the medical equipment provider’s stock worth $275,000 after buying an additional 192 shares in the last quarter. Dalton Greiner Hartman Maher & Co. purchased a new stake in shares of Integer in the second quarter worth $7,786,000. First National Bank of Omaha purchased a new stake in shares of Integer in the second quarter worth $4,068,000. Finally, Tributary Capital Management LLC purchased a new stake in shares of Integer in the second quarter worth $394,000. 99.39% of the stock is owned by institutional investors and hedge funds.
In other Integer news, Director Pamela G. Bailey sold 7,446 shares of the firm’s stock in a transaction dated Tuesday, November 5th. The stock was sold at an average price of $76.75, for a total transaction of $571,480.50. Following the sale, the director now owns 56,990 shares in the company, valued at $4,373,982.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Company insiders own 2.24% of the company’s stock.
Integer (NYSE:ITGR) last issued its quarterly earnings data on Thursday, October 31st. The medical equipment provider reported $1.20 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $1.06 by $0.14. Integer had a return on equity of 13.47% and a net margin of 8.99%. The company had revenue of $303.59 million for the quarter, compared to the consensus estimate of $313.78 million. During the same quarter last year, the business posted $1.06 earnings per share. The firm’s revenue was down .5% compared to the same quarter last year. On average, sell-side analysts forecast that Integer Holdings Corp will post 4.62 EPS for the current fiscal year.
A number of equities research analysts recently issued reports on ITGR shares. Northcoast Research reiterated a “buy” rating on shares of Integer in a research report on Friday, August 2nd. ValuEngine downgraded Integer from a “hold” rating to a “sell” rating in a research report on Friday, August 2nd. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and one has issued a buy rating to the stock. The stock presently has a consensus rating of “Hold” and an average price target of $65.76.
Integer Holdings Corporation operates as a medical device outsource manufacturer worldwide. It operates in two segments, Medical and Non-Medical. The company offers products for vascular, cardiac surgery, and structural heart diseases; peripheral vascular, neurovascular, urology, and oncology products; and electrophysiology, infusion therapy, and hemodialysis products.
Recommended Story: Fundamental Analysis – How It Helps Investors
Want to see what other hedge funds are holding ITGR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Integer Holdings Corp (NYSE:ITGR).
Receive News & Ratings for Integer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integer and related companies with MarketBeat.com's FREE daily email newsletter.